Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2006

01.05.2006 | Original Article

Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer

verfasst von: A. Papanikolaou, I. Kalogiannidis, M. Goutzioulis, D. Misailidou, A. Makedos, I. Vergote, G. Makedos

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2006

Einloggen, um Zugang zu erhalten

Abstract

Objective: The purpose of the study is to evaluate whether surgery followed by radiotherapy in high-risk patients of early stage endometrial cancer can be replaced by formal surgical staging. Cancer-related survival and recurrence-free survival (RFS) were the endpoints of the analysis. Study design: One hundred and eighteen patients with endometrioid endometrial adenocarcinoma between 1996–2003 were reviewed. Patients with incomplete follow-up and extrauterine spread excluded, leaving 78 women in the final analysis. Low-risk patients (n=37) (Grade 1, myometrial infiltration <1/2 or Grade2, <1/3), treated by standard surgical procedure including total abdominal hysterectomy, bilateral salpingo-oophorectomy and peritoneal washing, while staging lymphadenectomy (n=24) or postoperative irradiation (n=17) was added in the high-risk group (Grade 1, >1/2 or Grade 2, >1/3 or Grade3). Results: The median age of patients was 65 years (range, 35–80 years) and the median follow-up 38 months (range, 9–98 months). The recurrence rate in low-risk patients was 2.7%, the cancer-related survival 97.5% and RFS 97%, while in the high-risk patients 12%, 93% and 88%, respectively. Comparing the therapeutic modalities (staging lymphadenectomy vs. postoperative irradiation) in the high-risk group the cancer-related survival and RFS was not differed (P=0.70, P=0.90, respectively). The high grade of the tumor was significantly correlated with RFS, while age, stage and myometrial infiltration were not. No moderate or severe complications developed after lymphadenectomy, while two moderate gastrointestinal complications occurred after adjuvant radiotherapy. Conclusion: According our results the low-risk patients of early stage endometrial adenocarcinoma had excellent survival with minimal intervention. The cancer-related survival and RFS in high-risk patients concerning the therapeutic modalities were comparable. Poor tumor differentiation was the most unfavorable prognostic factor related with RFS. Moderate complications developed only after postoperative radiotherapy.
Literatur
1.
Zurück zum Zitat Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma clinical and histopathologic study of 540 patients. Obstet Gynecol 56:419–427PubMed Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma clinical and histopathologic study of 540 patients. Obstet Gynecol 56:419–427PubMed
2.
Zurück zum Zitat Amant F, Moerman P, Neven P, Timmerman D, VanLimbergen E, Vergote I (2005) Endomatrial cancer. Lancet 366:491–505PubMedCrossRef Amant F, Moerman P, Neven P, Timmerman D, VanLimbergen E, Vergote I (2005) Endomatrial cancer. Lancet 366:491–505PubMedCrossRef
3.
Zurück zum Zitat Ayhan A, Taskiran C, Celik C et al (2002) Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage endometrial cancer? Gynecol Oncol 86:259–263PubMedCrossRef Ayhan A, Taskiran C, Celik C et al (2002) Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage endometrial cancer? Gynecol Oncol 86:259–263PubMedCrossRef
4.
Zurück zum Zitat Ball HG (1996) Do we know the best therapy for the early stage endometrial cancer? Gynecol Oncol 60:173–175PubMedCrossRef Ball HG (1996) Do we know the best therapy for the early stage endometrial cancer? Gynecol Oncol 60:173–175PubMedCrossRef
5.
Zurück zum Zitat Belinson JL, Lee KR, Badger GL, Pretorius RG, Jarre MA (1992) Clinical stage I adenocarcinoma of the endometrium, analysis of the reoccurrences and the potentional benefit of staging lymphadenectomy. Gynecol Oncol 44:17–23PubMedCrossRef Belinson JL, Lee KR, Badger GL, Pretorius RG, Jarre MA (1992) Clinical stage I adenocarcinoma of the endometrium, analysis of the reoccurrences and the potentional benefit of staging lymphadenectomy. Gynecol Oncol 44:17–23PubMedCrossRef
6.
Zurück zum Zitat Chassagne D, Sismondi P, Horiot JC et al (1993) A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 26:183–202CrossRef Chassagne D, Sismondi P, Horiot JC et al (1993) A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 26:183–202CrossRef
7.
Zurück zum Zitat COSA-NZ-UK Endometrial Cancer Study Groups (1996) Pelvic lymphadenectomy in high-risk endometrial cancer. Int J Gynecol Cancer 6:102–107CrossRef COSA-NZ-UK Endometrial Cancer Study Groups (1996) Pelvic lymphadenectomy in high-risk endometrial cancer. Int J Gynecol Cancer 6:102–107CrossRef
8.
Zurück zum Zitat Cragun JM, Havrilesky LJ, Calingaert B et al (2005) Retrospective analysis of selective lymphadenectomy in apparent early stage endometrial cancer. J Clin Oncol 23:3653–3655CrossRef Cragun JM, Havrilesky LJ, Calingaert B et al (2005) Retrospective analysis of selective lymphadenectomy in apparent early stage endometrial cancer. J Clin Oncol 23:3653–3655CrossRef
9.
Zurück zum Zitat Creasman WT (1990) New gynecology cancer staging. Obstet Gynecol 75:287–288PubMed Creasman WT (1990) New gynecology cancer staging. Obstet Gynecol 75:287–288PubMed
10.
Zurück zum Zitat Creasman WT, Morrow C, Bundy B, Homesley H, Graham J, Heller P (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecology Oncology Group study. Cancer 60:2035–2041PubMedCrossRef Creasman WT, Morrow C, Bundy B, Homesley H, Graham J, Heller P (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecology Oncology Group study. Cancer 60:2035–2041PubMedCrossRef
11.
Zurück zum Zitat Creutzberg CL, Putten WLJ, Koper PCM et al for the PORTEC Study group (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage I endometrial Carcinoma multicenter randomized trial. Lancet 355:1404–1411 Creutzberg CL, Putten WLJ, Koper PCM et al for the PORTEC Study group (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage I endometrial Carcinoma multicenter randomized trial. Lancet 355:1404–1411
12.
Zurück zum Zitat DiSaia PJ, Creasman WT, Boronow RC, Blessing JA (1985) Risk factors and recurrence patterns in stage I endometrial cancer. Am J Obstet Gynecol 151:1009–1015PubMed DiSaia PJ, Creasman WT, Boronow RC, Blessing JA (1985) Risk factors and recurrence patterns in stage I endometrial cancer. Am J Obstet Gynecol 151:1009–1015PubMed
13.
Zurück zum Zitat Gatta G, Lasota MB, Verfecchia A, the EUROCARE Working Group (1998) Survival of European women with gynaecological tumours during the period 1978–1989. Eur J Cancer 34:2218–2225CrossRef Gatta G, Lasota MB, Verfecchia A, the EUROCARE Working Group (1998) Survival of European women with gynaecological tumours during the period 1978–1989. Eur J Cancer 34:2218–2225CrossRef
14.
Zurück zum Zitat Goudge C, Bernhard S, Cloven NG, Morris P (2004) The impact of complete surgical staging on adjuvant treatment decision in endometrial cancer. Gynecol Oncol 93:536–539PubMedCrossRef Goudge C, Bernhard S, Cloven NG, Morris P (2004) The impact of complete surgical staging on adjuvant treatment decision in endometrial cancer. Gynecol Oncol 93:536–539PubMedCrossRef
15.
Zurück zum Zitat Homesley HD, Kadar N, Barrett RJ, Lentz SS (1992) Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am J Obstet Gynecol 167:1225–1230PubMed Homesley HD, Kadar N, Barrett RJ, Lentz SS (1992) Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am J Obstet Gynecol 167:1225–1230PubMed
16.
Zurück zum Zitat Kaplan EL, Meier P (1958) Non parametric estimation for incomplete observations. J Am Stat Assoc 53:457–481CrossRef Kaplan EL, Meier P (1958) Non parametric estimation for incomplete observations. J Am Stat Assoc 53:457–481CrossRef
17.
Zurück zum Zitat Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol 92:744–751PubMedCrossRef Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol 92:744–751PubMedCrossRef
18.
Zurück zum Zitat Kilgore LC, Patridge EE, Alvarez RD et al (1995) Adenocarcinoma of the endometrium. Survival comparison of patients with and without pelvic node sampling. Gynecol Oncol 56:29–33PubMedCrossRef Kilgore LC, Patridge EE, Alvarez RD et al (1995) Adenocarcinoma of the endometrium. Survival comparison of patients with and without pelvic node sampling. Gynecol Oncol 56:29–33PubMedCrossRef
19.
Zurück zum Zitat Kitchener HC, Redman CW, Swart AMC, Amos CL (2005) ASTEC (Surgery component) A study in the treatment of endometrial cancer. A randomized trial of lymphadenectomy in the treatment of the endometrial cancer (Abstract book). Int J Gynecol Cancer 15:77 Kitchener HC, Redman CW, Swart AMC, Amos CL (2005) ASTEC (Surgery component) A study in the treatment of endometrial cancer. A randomized trial of lymphadenectomy in the treatment of the endometrial cancer (Abstract book). Int J Gynecol Cancer 15:77
20.
Zurück zum Zitat Larson DM, Broste SK, Krawist BR (1998) Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 91:355–359PubMedCrossRef Larson DM, Broste SK, Krawist BR (1998) Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 91:355–359PubMedCrossRef
21.
Zurück zum Zitat Larson DM, Connor GP, Broste SK, Krawist BR, Johnson KK (1996) Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 88:394–398PubMedCrossRef Larson DM, Connor GP, Broste SK, Krawist BR, Johnson KK (1996) Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 88:394–398PubMedCrossRef
22.
Zurück zum Zitat Lo KWK, Cheung TH, Yu MY, Yim SF, Chung TKH (2003) The value of pelvic and paraaortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy. Int J Gynecol Cancer 13: 863–869PubMedCrossRef Lo KWK, Cheung TH, Yu MY, Yim SF, Chung TKH (2003) The value of pelvic and paraaortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy. Int J Gynecol Cancer 13: 863–869PubMedCrossRef
23.
Zurück zum Zitat Mariani A, Sebo TJ, Katzmann JA et al (2005) Endometrial cancer: can nodal status be predicted with curettage. Gynecol Oncol 96:594–600PubMedCrossRef Mariani A, Sebo TJ, Katzmann JA et al (2005) Endometrial cancer: can nodal status be predicted with curettage. Gynecol Oncol 96:594–600PubMedCrossRef
24.
Zurück zum Zitat Mohan DS, Samuels MA, Selim MA et al (1998) Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 70:165–171PubMedCrossRef Mohan DS, Samuels MA, Selim MA et al (1998) Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 70:165–171PubMedCrossRef
25.
Zurück zum Zitat Orr JW Jr, Holimon JL, Orr PF (1997) Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol 176:777–788PubMedCrossRef Orr JW Jr, Holimon JL, Orr PF (1997) Stage I corpus cancer: is teletherapy necessary? Am J Obstet Gynecol 176:777–788PubMedCrossRef
26.
Zurück zum Zitat Potish RA, Dusenbury KE (1990) Enteric of postoperative pelvic external beam and brachytherapy for uterine cancer. Int J Oncol Biol Phys 18:1005–1010 Potish RA, Dusenbury KE (1990) Enteric of postoperative pelvic external beam and brachytherapy for uterine cancer. Int J Oncol Biol Phys 18:1005–1010
27.
Zurück zum Zitat Sabbatini PJ, Kaled MA. Barakat R (2000) Endometrial cancer. Handbook of gynecologic oncology.2nd edn. Martin Dunitz Publisher, London pp 283–296 Sabbatini PJ, Kaled MA. Barakat R (2000) Endometrial cancer. Handbook of gynecologic oncology.2nd edn. Martin Dunitz Publisher, London pp 283–296
28.
Zurück zum Zitat Shachar IB, Pavelka J, Cohn D et al (2005) Surgical staging for patients presenting with grade I endometrial carcinoma. Obstet Gynecol 105:487–493 Shachar IB, Pavelka J, Cohn D et al (2005) Surgical staging for patients presenting with grade I endometrial carcinoma. Obstet Gynecol 105:487–493
29.
Zurück zum Zitat Straughn JM Jr, Huh WK, Orr JW Jr et al (2003) Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol 89:295–300PubMedCrossRef Straughn JM Jr, Huh WK, Orr JW Jr et al (2003) Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol 89:295–300PubMedCrossRef
30.
Zurück zum Zitat Trimble EL, Kosary C, Park RC (1998) Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 71:340–343PubMedCrossRef Trimble EL, Kosary C, Park RC (1998) Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 71:340–343PubMedCrossRef
31.
Zurück zum Zitat Wolfson AH, Sightier SE, Markoe AM et al (1992) The prognostic significance of surgical staging for carcinoma of endometrium. Gynecol Oncol 45:142–146PubMedCrossRef Wolfson AH, Sightier SE, Markoe AM et al (1992) The prognostic significance of surgical staging for carcinoma of endometrium. Gynecol Oncol 45:142–146PubMedCrossRef
32.
Zurück zum Zitat Zaino RJ, Kurman RJ, Diana KL, Morrow CP (1996) Pathologic model to predict outcome for women with endometrial adenocarcinoma. Cancer 77:1115–1121PubMedCrossRef Zaino RJ, Kurman RJ, Diana KL, Morrow CP (1996) Pathologic model to predict outcome for women with endometrial adenocarcinoma. Cancer 77:1115–1121PubMedCrossRef
Metadaten
Titel
Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer
verfasst von
A. Papanikolaou
I. Kalogiannidis
M. Goutzioulis
D. Misailidou
A. Makedos
I. Vergote
G. Makedos
Publikationsdatum
01.05.2006
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2006
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-006-0138-y

Weitere Artikel der Ausgabe 2/2006

Archives of Gynecology and Obstetrics 2/2006 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.